Dividend announcement and upcoming earnings draw attention

Brown & Brown (BRO) has affirmed a quarterly dividend of US$0.165 per share, payable on August 19, 2026, with an ex dividend and record date of August 12, 2026, as investors watch the upcoming earnings report.

See our latest analysis for Brown & Brown.

Brown & Brown’s share price has recently firmed, with a 1 day share price return of 2.92% and a 30 day share price return of 5.36%. However, year to date the share price is down 12.83% and the 1 year total shareholder return has declined 33.97%, pointing to fading momentum over the past year despite the upcoming earnings and dividend.

If you are weighing Brown & Brown against other opportunities, this could be a good moment to broaden your search with the 18 top founder-led companies

Brown & Brown looks like a solid insurance broker on the surface, and the recent share price rebound ahead of earnings underlines that. The key question is whether you are paying a fair price for that quality today or stretching for it.

Most Popular Narrative: 7.8% Undervalued

The most followed valuation narrative currently places Brown & Brown’s fair value at $73.38 compared with a last close of $67.66, framing the stock as modestly discounted ahead of earnings.

Strong cash flow from operations, combined with a strategic focus on leveraging a diversified portfolio across geographies and lines of business, positions the company to navigate economic uncertainties and potentially increase future earnings stability and growth.

Read the complete narrative.

Want to see what sits behind that fair value for Brown & Brown? The narrative leans on steady top line expansion, pressure on margins, and a richer future earnings multiple. The mix of growth, profitability assumptions, and valuation expectations is doing all the heavy lifting.

Result: Fair Value of $73.38 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Brown & Brown’s story could be knocked off course if tariffs and inflation slow client activity, or if changing insurance rules in Florida lift costs faster than expected.

Find out about the key risks to this Brown & Brown narrative.

Another view on Brown & Brown’s valuation

The first narrative paints Brown & Brown as undervalued using future earnings and a higher assumed P/E. On current numbers, though, the stock trades on a 20.2x P/E, which is richer than both the US Insurance industry at 12.4x and a fair ratio of 13x, pointing to valuation risk if sentiment cools.

Before you lean too much on any single yardstick, it can help to see what the numbers say about this price in more detail, so take a look at the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With mixed signals around Brown & Brown’s valuation and outlook, it makes sense to review the data yourself and decide where you stand. To see how the balance of concerns and potential upsides compares in one place, take a look at the 3 key rewards and 1 important warning sign

Looking for more Brown & Brown investment ideas?

If the Brown & Brown story has you thinking more broadly about your portfolio, this is the moment to widen your search and compare fresh opportunities.

• Target reliable payouts and potential income resilience by scanning companies that stand out in our 9 dividend fortresses.
• Zero in on quality at a compelling price point by filtering stocks through the 49 high quality undervalued stocks.
• Strengthen your downside protection by focusing on companies highlighted in the 79 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.